- Home
- MDXG vs SDHC Comparison
MDXG vs SDHC Comparison
Compare MDXG & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- SDHC
- Stock Information
- Founded
- MDXG 2006
- SDHC 2008
- Country
- MDXG United States
- SDHC United States
- Employees
- MDXG N/A
- SDHC N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- SDHC
- Sector
- MDXG Health Care
- SDHC
- Exchange
- MDXG Nasdaq
- SDHC Nasdaq
- Market Cap
- MDXG 1.0B
- SDHC 1.0B
- IPO Year
- MDXG N/A
- SDHC 2024
- Fundamental
- Price
- MDXG $7.05
- SDHC $19.03
- Analyst Decision
- MDXG Strong Buy
- SDHC Hold
- Analyst Count
- MDXG 3
- SDHC 4
- Target Price
- MDXG $12.00
- SDHC $30.25
- AVG Volume (30 Days)
- MDXG 812.0K
- SDHC 34.2K
- Earning Date
- MDXG 04-30-2025
- SDHC 05-14-2025
- Dividend Yield
- MDXG N/A
- SDHC N/A
- EPS Growth
- MDXG N/A
- SDHC N/A
- EPS
- MDXG 0.27
- SDHC 1.81
- Revenue
- MDXG $352,375,000.00
- SDHC $975,463,000.00
- Revenue This Year
- MDXG $9.23
- SDHC $6.82
- Revenue Next Year
- MDXG $11.49
- SDHC $11.61
- P/E Ratio
- MDXG $26.15
- SDHC $10.54
- Revenue Growth
- MDXG 5.34
- SDHC 27.57
- 52 Week Low
- MDXG $5.47
- SDHC $17.03
- 52 Week High
- MDXG $10.14
- SDHC $39.50
- Technical
- Relative Strength Index (RSI)
- MDXG 51.34
- SDHC 46.12
- Support Level
- MDXG $6.53
- SDHC $18.56
- Resistance Level
- MDXG $7.07
- SDHC $19.46
- Average True Range (ATR)
- MDXG 0.33
- SDHC 0.80
- MACD
- MDXG 0.10
- SDHC 0.01
- Stochastic Oscillator
- MDXG 68.03
- SDHC 24.52
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.